Cite
HARVARD Citation
Levi, S. et al. (2023). Efficacy of front‐line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter "Real‐World" study. American journal of hematology. 98 (2), pp. E24-E27. [Online].